Journal of Experimental Medicine, Vol 178, 1121-1126, Copyright © 1993 by Rockefeller University Press

ARTICLES

A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity

H Maiza, G Leca, IG Mansur, V Schiavon, L Boumsell and A Bensussan
Laboratoire INSERM U93, Association Claude Bernard, Hopital Saint- Louis, Paris, France.

Human lymphocytes with natural killer (NK) activity, including most activated gamma/delta+ T lymphocytes, recognize and lyse tumor target cells without requiring recognition of major histocompatibility complex antigen. However, unlike gamma/delta+ T lymphocytes, NK cells do not express CD3/T cell receptor (TCR) molecules, and the receptors involved in cell-mediated cytotoxicity are unknown. To further delineate circulating NK cells, we developed monoclonal antibodies (mAbs) against the human NK leukemia YT2C2. We report the isolation of a mAb termed BY55, recognizing at the cell surface a novel 80-kD protein with restricted expression. In addition to the immunizing cell line, this mAb binds to circulating NK cells, gamma/delta+ cells, and a minor subset of alpha/beta+ T lymphocytes. Expression of the BY55 mAb- reactive epitope/molecule is regulated by activation, as short-term culture of peripheral blood lymphocytes (PBL) with phorbol ester induced its downmodulation. Furthermore, BY55 mAb reactivity was found neither with the NK nor with the TCR alpha/beta+ gamma/delta+ clones tested. Biochemical studies as well as phenotypic analysis revealed that this structure is different from all previously identified molecules on the lymphocyte cell surface. Interestingly, we found that BY55+ cells exert most NK activity obtained with fresh circulating lymphocytes. We report that within fresh E rosette-positive PBL only a subset of the CD16+, CD56+, and CD57+ cells coexpressed BY55 molecule, indicating that BY55 mAb defines a unique subset mediating NK activity of circulating PBL.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• El Costa, H., Casemayou, A., Aguerre-Girr, M., Rabot, M., Berrebi, A., Parant, O., Clouet-Delannoy, M., Lombardelli, L., Jabrane-Ferrat, N., Rukavina, D., Bensussan, A., Piccinni, M.-P., Le Bouteiller, P., Tabiasco, J. (2008). Critical and Differential Roles of NKp46- and NKp30-Activating Receptors Expressed by Uterine NK Cells in Early Pregnancy. J. Immunol. 181: 3009-3017 [Abstract] [Full Text]  
• Giustiniani, J., Marie-Cardine, A., Bensussan, A. (2007). A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity. J. Immunol. 178: 1293-1300 [Abstract] [Full Text]  
• Fons, P., Chabot, S., Cartwright, J. E., Lenfant, F., L'Faqihi, F., Giustiniani, J., Herault, J.-P., Gueguen, G., Bono, F., Savi, P., Aguerre-Girr, M., Fournel, S., Malecaze, F., Bensussan, A., Plouet, J., Le Bouteiller, P. (2006). Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108: 2608-2615 [Abstract] [Full Text]  
• Maeda, M., Carpenito, C., Russell, R. C., Dasanjh, J., Veinotte, L. L., Ohta, H., Yamamura, T., Tan, R., Takei, F. (2005). Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation. J. Immunol. 175: 4426-4432 [Abstract] [Full Text]  
• Barakonyi, A., Rabot, M., Marie-Cardine, A., Aguerre-Girr, M., Polgar, B., Schiavon, V., Bensussan, A., Le Bouteiller, P. (2004). Cutting Edge: Engagement of CD160 by its HLA-C Physiological Ligand Triggers a Unique Cytokine Profile Secretion in the Cytotoxic Peripheral Blood NK Cell Subset. J. Immunol. 173: 5349-5354 [Abstract] [Full Text]  
• Le Bouteiller, P., Barakonyi, A., Giustiniani, J., Lenfant, F., Marie-Cardine, A., Aguerre-Girr, M., Rabot, M., Hilgert, I., Mami-Chouaib, F., Tabiasco, J., Boumsell, L., Bensussan, A. (2002). Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl. Acad. Sci. USA 99: 16963-16968 [Abstract] [Full Text]  
• Nikolova, M., Marie-Cardine, A., Boumsell, L., Bensussan, A. (2002). BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int Immunol 14: 445-451 [Abstract] [Full Text]  
• Poszepczynska, E., Bagot, M., Echchakir, H., Martinvalet, D., Ramez, M., Charue, D., Boumsell, L., Bensussan, A. (2000). Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 96: 1056-1063 [Abstract] [Full Text]  
• Agrawal, S., Marquet, J., Freeman, G. J., Tawab, A., Bouteiller, P. L., Roth, P., Bolton, W., Ogg, G., Boumsell, L., Bensussan, A. (1999). Cutting Edge: MHC Class I Triggering by a Novel Cell Surface Ligand Costimulates Proliferation of Activated Human T Cells. J. Immunol. 162: 1223-1226 [Abstract] [Full Text]  
• Anumanthan, A., Bensussan, A., Boumsell, L., Christ, A. D., Blumberg, R. S., Voss, S. D., Patel, A. T., Robertson, M. J., Nadler, L. M., Freeman, G. J. (1998). Cloning of BY55, a Novel Ig Superfamily Member Expressed on NK Cells, CTL, and Intestinal Intraepithelial Lymphocytes. J. Immunol. 161: 2780-2790 [Abstract] [Full Text]  
• Bagot, M., Echchakir, H., Mami-Chouaib, F., Delfau-Larue, M.-H., Charue, D., Bernheim, A., Chouaib, S., Boumsell, L., Bensussan, A. (1998). Isolation of Tumor-Specific Cytotoxic CD4+ and CD4+CD8dim+ T-Cell Clones Infiltrating a Cutaneous T-Cell Lymphoma. Blood 91: 4331-4341 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS